13


Standalone Result
Segment 
Scrip Code : 506820      Company : AstraZeneca Pharma India Ltd

TypeUn-AuditedUn-AuditedUn-AuditedUn-AuditedUn-AuditedAudited
Period Ending30-Sep-0930-Jun-0931-Mar-0931-Dec-0830-Sep-0831-Dec-08
No. of Months3333312
DescriptionAmount(Rs. million)
Net Sales / Interest Earned / Operating Income1,009.40992.24802.30970.10904.593,542.65
Other Income6.9511.4327.4256.9726.32138.76
Total Income1,016.351,003.67829.721,027.07930.913,681.41
Expenditure-812.33-748.06-694.12-642.01-610.85-2,420.25
Interest---1.37-12.60-12.60-48.63
Profit Before Depreciation and Tax204.02255.61134.23372.46307.461,212.53
Depreciation-15.32-15.19-14.62-19.80-19.42-68.76
Profit before Tax188.70240.42119.62352.67288.041,143.76
Tax-58.98-87.57-46.87-123.50-103.37-405.41
Net Profit129.72152.8472.75229.17184.67738.35
Equity Capital50.0050.0050.0050.0050.0050.00
Basic And Diluted EPS after Extraordinary item5.196.112.919.177.3929.53
Nos. of Shares - Public2,500,050.002,500,050.002,500,050.002,500,050.002,500,050.002,500,050.00
Percent of Shares-Public10.0010.0010.0010.0010.0010.00
Operating Profit Margin20.2125.7616.9039.6935.3835.60
Net Profit Margin12.8515.409.0723.6220.4120.84
Cash EPS5.806.723.499.968.1632.28
 NotesNotesNotesNotesNotesNotes
DetailedDetailedDetailedDetailedDetailedDetailed


Note :1. The results displayed here are as furnished by the company at the relevant point of time.
2. Operating Profit Margin, Net Profit Margin and Cash EPS is calculated and not furnished by the company.
3. Quarterly, Half Yearly, Annual will be displayed for current period and 3 immediately preceding periods.
4. Where no data is available for any of the immediately preceding period, then there will be no display for     that period.
 
Contact Information | Company Results | Announcements | Shareholding Pattern | Stock Reach | Charting | Archives